Nuvalent shares jump 38% on GSK's $10.6 billion acquisition deal

2 min read     Updated on 09 Jun 2026, 02:57 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Nuvalent, Inc shares surged 38.2% in pre-market trading after GSK agreed to acquire the company for $10.6 billion, or $124 per share in cash. The deal represents a 40% premium over Nuvalent's closing price on Monday. Other notable movers included CCSC Technology International Hldngs Ltd, which gained 651.2%, and Inotiv Inc, which fell 34.4% after filing for chapter 11 bankruptcy.

powered bylight_fuzz_icon
42542809

*this image is generated using AI for illustrative purposes only.

Nuvalent, Inc shares rose 38.2% to $122.56 in pre-market trading after GSK agreed to acquire the company in a deal valued at $10.6 billion. GSK will pay $124 per share in cash, a 40% premium over Nuvalent's closing share price on Monday. The acquisition underscores strategic moves by major pharmaceutical firms to bolster their oncology pipelines.

Other Market Movers

Several other stocks experienced significant volatility during pre-market trading. CCSC Technology International Hldngs Ltd gained 651.2% to $3.60, while Core AI Holdings Inc rose 564.6% to $5.45. Regentis Biomaterials Ltd gained 211% to $3.98, and Mingteng International Corp Inc added 76.8% to $3.43 after surging 81% on Monday.

Nocera Inc jumped 66.7% to $0.22 after announcing a binding agreement with Digital Innovations Group to establish Digital Innovations Venture Group. Zenta Group Co Ltd rose 54.3% to $3.92, and Epsium Enterprise Ltd increased 45.6% to $1.73. Designer Brands Inc climbed 20.8% to $10.73 ahead of quarterly earnings, while Applied Digital Corp gained 10.3% to $45.18 following a lease agreement for Delta Forge 2.

Decliners

Park Ha Biological Technology Co Ltd tumbled 44.2% to $1.48 after gaining around 150% on Monday. Inotiv Inc fell 34.4% to $0.073 after announcing it filed a voluntary, prepackaged chapter 11 case following a restructuring support deal with lenders and noteholders. iTonic Holdings Ltd dropped 33.4% to $0.34, and Texxon Holding Ltd fell 32.3% to $3.34.

MetaVia Inc declined 22.2% to $1.72 as shareholders approved a reverse stock split. Galaxy Payroll Group Ltd decreased 22.1% to $0.87, and Highway Holdings Ltd lost 17.2% to $0.60. A Paradise Acquisition Corp fell 11.3% to $3.05, while Ideaya Biosciences Inc dipped 10.8% to $28.09 after pricing a $300 million offering of common stock and pre-funded warrants. Wipro Ltd dropped 7% to $2.03.

Company Ticker Pre-Market Change Price
Nuvalent, Inc NUVL +38.2% $122.56
CCSC Technology International Hldngs Ltd CCTG +651.2% $3.60
Core AI Holdings Inc CHAI +564.6% $5.45
Regentis Biomaterials Ltd RGNT +211% $3.98
Mingteng International Corp Inc MTEN +76.8% $3.43
Nocera Inc NCRA +66.7% $0.22
Zenta Group Co Ltd ZTG +54.3% $3.92
Epsium Enterprise Ltd EPSM +45.6% $1.73
Designer Brands Inc DBI +20.8% $10.73
Applied Digital Corp APLD +10.3% $45.18
Park Ha Biological Technology Co Ltd BYAH -44.2% $1.48
Inotiv Inc NOTV -34.4% $0.073
iTonic Holdings Ltd ITOC -33.4% $0.34
Texxon Holding Ltd NPT -32.3% $3.34
MetaVia Inc MTVA -22.2% $1.72
Galaxy Payroll Group Ltd GLXG -22.1% $0.87
Highway Holdings Ltd HIHO -17.2% $0.60
A Paradise Acquisition Corp ENHA -11.3% $3.05
Ideaya Biosciences Inc IDYA -10.8% $28.09
Wipro Ltd WIT -7% $2.03

How will GSK's acquisition of Nuvalent impact its competitive position in the oncology market?

What are the potential regulatory hurdles for the Nuvalent acquisition?

Will this deal trigger further consolidation in the pharmaceutical sector?

like18
dislike